Skip to main content

Table 1 Patients’ baseline and tumor parameters

From: Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus

Parameter

nCRT + S (n = 40)

dCRT (n = 55)

p-value

Age, (years)

 Median

65

68

0.079

 IQR

56–72

62–74

Male sex

22 (55%)

40 (73%)

0.085

T-stage (cT)

 Tis

0 (0%)

1 (2%)

0.148

 T1

1 (3%)

3 (5%)

 T2

7 (18%)

8 (15%)

 T3

32 (80%)

37 (67%)

 T4

0 (0%)

6 (11%)

N-stage (cN)

 N+

40 (100%)

47 (85%)

0.019

Grading

 G1

1 (3%)

0 (0%)

0.729

 G2

20 (53%)

26 (53%)

 G3

17 (45%)

23 (47%)

Tumor length, (cm)

 Median

5

5

0.445

 IQR

3–7

4–7

Distance from dental arch to cranial tumor border, (cm)

 Median

26

20

< 0.001

 IQR

24–30

17–26

Tumor location

 Cervical

4 (10%)

26 (47%)

< 0.001

 Thoracic

35 (88%)

28 (51%)

 Abdominal

1 (3%)

1 (2%)

Cumulative RT dose, (Gy)

 Median

41.4

54

< 0.001

 IQR

41.4–45

54–59.4

Complete tumor resection

36 (97%)

  1. IQR inter-quartiles-range, Gy Gray, RT radiotherapy